News

Cambridge UK – 7 April 2021 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is excited to announce its latest patient group partnerships. Working in collaboration with Ataxia UK and FARA, Healx will leverage its state-of-the-art AI platform and drug discovery expertise to develop novel … Continued

The development of clinically-relevant, robust and sensitive outcome measures is an essential component of designing meaningful clinical trials to test the effects of treatments for rare diseases. During this 60-minute webinar, our panel of speakers discuss the following topics: General principles for developing outcome measures based on their experiences in this field The challenges COVID-19 … Continued